20 BolanosJ
Tirzepatide shows 5-8% greater weight loss in studies than semaglutide, says Lyla Joffe, RD, and many patients report feeling fuller on lower dosages, too
For your longevity goals Support healthy aging with a plan built around you For your longevity goals Support healthy aging with a plan built around you For your longevity goals Support healthy aging with a plan built around you For your longevity goals Support healthy aging with a plan built around you Why Physician Oversight Matters More After This Announcement, Not Less Why Physician Oversight Matters More After This Announcement, Not Less There is a version of this story that is told as a liberation narrative: the FDA is stepping back, peptides are returning, and patients can now access what was taken from them
In a study (New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes) published on February 12, 2026, participants who started taking semaglutide were about 2 times more likely to develop NAION than participants who took sodium-glucose cotransporter-2 inhibitors
After embedding in paraffin, 5 M sections were cut for IHC
